Diplomat Pharmacy (DPLO) PT Raised to $40 at Credit Suisse

Credit Suisse analyst G. Santangelo raised its price target on Outperform-rated Diplomat Pharmacy (NYSE: DPLO) to $40.00 (from $37.00) following Q1 'beat and raise'.

For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.

Shares of Diplomat Pharmacy closed at $36.11 yesterday.

You May Also Be Interested In

• Deutsche Bank Upgrades Sirius XM Radio (SIRI) to Buy, 'mispriced based on a large disconnect between consensus estimates and what we believe the company can achieve
• salesforce.com (CRM) PT Raised to $300 at Cantor Fitzgerald as 'Stock Deserves a Higher Multiple'
• Stitch Fix, Inc. (SFIX) PT Lowered to $4 at UBS